The intestine as a regulator of cholesterol homeostasis in diabetes.

Diabetes Institute of Ireland, Beacon Clinic Dublin, and Blackrock Clinic Dublin, Department of Medicine, Trinity College, Dublin, Ireland.
Atherosclerosis Supplements (Impact Factor: 9.67). 09/2008; 9(2):27-32. DOI: 10.1016/j.atherosclerosissup.2008.05.012
Source: PubMed

ABSTRACT The chylomicron influences very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) composition but itself is atherogenic. Thus abnormalities of chylomicron production are of interest particularly in conditions such as diabetes which confer major cardiovascular risk. Intestinal function is abnormal in diabetes and is a major cause of the dyslipidaemia found in this condition. Studies have suggested that cholesterol absorption is decreased in diabetes and cholesterol synthesis increased. Molecular mechanisms involved in insulin resistance in the intestine and its effect on cholesterol homeostasis in diabetes are described. Abnormalities in triglyceride synthesis and alterations genes regulating cholesterol absorption and intestinal synthesis are discussed. In particular, increase in apolipoprotein B48 synthesis has been demonstrated in animal models of diabetes and insulin resistance. Intestinal mRNA expression of Niemann Pick C1-like 1, protein is increased in both experimental and human diabetes suggesting that an increase in cholesterol transportation does occur. mRNA expression of the ATP binding cassette proteins (ABC) G5 and G8, two proteins working in tandem to excrete cholesterol have been shown to be decreased suggesting increased delivery of cholesterol for absorption. Expression of microsomal triglyceride transfer protein, which assembles the chylomicron particle, is increased in diabetes leading to increase in both number and cholesterol content. In conclusion, diabetes is associated with considerable dysfunction of the intestine leading to abnormal chylomicron composition which may play a major part in the premature development of atherosclerosis.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Flow regimes have become a fundamental part of ecological informatics to reveal the complex interactional mechanism lying between flow regimes and ecological system. In this study, the changes of flow regimes were investigated to obtain the suitable flow regimes for maintaining the ecological integrity in the Lower Yellow River, China. The temporal abrupt for annual streamflow was explored with Mann–Kendall method (M–K method), and alterations of flow regimes at daily scale were described in accordance with Indicators of Hydrologic Alteration (IHA) and Histogram Matching Approach (HMA). Results showed that: (i) the annual flow presented a downward abrupt in 1984, and after that year, the flow magnitude was smaller in general, and the frequency of low flow was much higher during all the twelve months; (ii) during the post-impact period, both of the maximum and minimum flow magnitudes for 1-day, 3-day, 7-day, 30-day and 90-day declined, and frequency distribution distances were larger than 70% except for 1-, 3-, 7- and 30-day minimum flows; (iii) the number and duration of low pulse extended for the post-impact period, whereas the number and duration of high pulse decreased; and (iv) suitable ranges of monthly magnitude as well as number and duration days for high/low pulses were obtained (e.g., 743 to 3979m3/s for monthly flow magnitude in July, August, September, October and November with similar target ranges, from 94 to 1075m3/s for the rest seven months). The results indicate that the flow magnitude of the Yellow River has a decreasing trend, and some critical hydrologic characteristics should be taken into account due to their importance for ecosystems health in the downstream Yellow River Basin.
    Ecological Informatics 01/2011; 10. DOI:10.1016/j.ecoinf.2011.10.002 · 1.98 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Diabetes mellitus is a worldwide epidemic with high mortality. As concern over this disease rises, the number and value of research grants awarded by the National Research Foundation of Korea (NRF) have increased. Diabetes mellitus is classified into two groups. Type 1 diabetes requires insulin treatment, whereas type 2 diabetes, which is characterized by insulin resistance, can be treated using a variety of therapeutic approaches. Hyperglycemia is thought to be a primary factor in the onset of diabetes, although hyperlipidemia also plays a role. The major organs active in the regulation of blood glucose are the pancreas, liver, skeletal muscle, adipose tissue, intestine, and kidney. Diabetic complications are generally classified as macrovascular (e.g., stroke and heart disease) or microvascular (i.e., diabetic neuropathy, nephropathy, and retinopathy). Several animal models of diabetes have been used to develop oral therapeutic agents, including sulfonylureas, biguanides, thiazolidinediones, acarbose, and miglitol, for both type 1 and type 2 diseases. This review provides an overview of diabetes mellitus, describes oral therapeutic agents for diabetes and their targets, and discusses new developments in diabetic drug research.
    Asian Australasian Journal of Animal Sciences 05/2010; 23(5). DOI:10.5713/ajas.2010.90637 · 0.56 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The expression of intestinal NPC1L1 cholesterol transporter has been shown to be elevated in patients with diseases associated with hypercholesterolemia such as diabetes mellitus. High levels of glucose were shown to directly increase the expression of NPC1L1 in intestinal epithelial cells but the underlying mechanisms are not fully defined. The current studies were, therefore, undertaken to examine the transcriptional regulation of NPC1L1 expression in human intestinal Caco2 cells in response to glucose. Removal of glucose from the culture medium of Caco2 cells for 24 h significantly decreased the NPC1L1 mRNA and protein expression as well as the promoter activity. Glucose replenishment significantly increased the promoter activity of NPC1L1 in a dose dependent manner as compared to control cells. Exposure of Caco2 cells to non-metabolizeable form of glucose, 3-O-methyl-D-glucopyranose (OMG) had no effect on NPC1L1 promoter activity indicating that the observed effects are dependent on glucose metabolism. Further, glucose-mediated increase in promoter activity was abrogated in the presence of okadiac acid suggesting the involvement of protein phosphatases. Glucose effects on several deletion constructs of NPC1L1 promoter demonstrated that cis-elements mediating the effects of glucose are located in the region between -291 and +56 of NPC1L1 promoter. Consistent with the effects of glucose removal on NPC1L1 expression in Caco2 cells, 24 h fasting resulted in a significant decrease in the relative expression of NPC1L1 in mouse jejunum. In conclusion, glucose appears to directly modulate NPC1L1 expression via a transcriptional mechanisms and the involvement of phosphatase-dependent pathways.
    AJP Gastrointestinal and Liver Physiology 11/2012; 304(2). DOI:10.1152/ajpgi.00288.2012 · 3.74 Impact Factor